VETOQUINOL news, videos and press releases
For more news please use our advanced search feature.
VETOQUINOL - More news...
VETOQUINOL - More news...
- Vetoquinol: Annual Results 2024
- Vetoquinol: Annual Sales 2024
- Vetoquinol: 2025 Calendar of Financial Communication
- In 2023, Vetoquinol Celebrates Its 90th Anniversary
- In 2023, Vetoquinol Celebrates Its 90th Anniversary
- 3rd Generation Appointed Chairman of the Board of Directors of Vetoquinol SA
- In 2023, Vetoquinol Celebrates Its 90th Anniversary
- In 2023, Vetoquinol Celebrates Its 90th Anniversary
- Vetoquinol: Q1 2023 Sales: €145M
- Vetoquinol: Availability of the 2022 Universal Registration Document
- In 2023, Vetoquinol Celebrates Its 90th Anniversary
- Vetoquinol: 2022 Annual Results
- In 2023 Vetoquinol Celebrates Its 90th Anniversary
- In 2023 Vetoquinol Celebrates Its 90th Anniversary
- Vetoquinol: Annual Sales 2022
- Vetoquinol: 2023 Calendar of Financial Communication
- Vetoquinol: First Nine Months 2022 Sales: €405M
- Vetoquinol 2022 Half Year Results: Additional Information on the Group’s Strategy
- Vetoquinol: 2022 Half Year Results
- Vetoquinol: H1 2022 Sales: €271m, up 6.1%
- Vetoquinol: Availability of the 2021 Universal Registration Document
- Vetoquinol: Q1 2022 Sales: €135M
- Vetoquinol: 2021 Annual Results
- Vetoquinol: Double-digit Growth In 2021
- Vetoquinol: 2022 Calendar of Financial Communication
- Felpreva®, Vetoquinol’s New Three-Monthly Feline Parasiticide, Receives Marketing Authorisation from the European Commission
- Vetoquinol: Third Quarter Revenues: €132 Million
- Veterinary Parasiticide Felpreva® (tigolaner / emodepside / praziquantel) Receives Positive Opinion From European Committee for Medicinal Products for Veterinary Use (CVMP)
- Vetoquinol: 2021 First Half Results
- Vetoquinol: Availability of the 2020 Universal Registration Document
